Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Cancer Communications (London, England)
|
January 5, 2023
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia, Hao Zhang, Haofeng Lu, et al.
Med (New York, N.Y.)
|
October 12, 2020
Kidney Function Indicators Predict Adverse Outcomes of COVID-19
Ye-Mao Liu, Jing Xie, Ming-Ming Chen, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou, Ye-Mao Liu, Jing Xie, et al.
Cell Metabolism
|
January 9, 2021
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
Jingjing Cai, Haomiao Li, Changjiang Zhang, et al.
Cell Metabolism
|
May 6, 2020
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu, Zhi-Gang She, Xu Cheng, et al.
Cell Metabolism
|
June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Current Medical Research and Opinion
|
March 17, 2021
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients
Ze Chen, Jing Chen, Jianghua Zhou, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Cancer Communications (London, England)
|
January 5, 2023
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia, Hao Zhang, Haofeng Lu, et al.
Med (New York, N.Y.)
|
October 12, 2020
Kidney Function Indicators Predict Adverse Outcomes of COVID-19
Ye-Mao Liu, Jing Xie, Ming-Ming Chen, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou, Ye-Mao Liu, Jing Xie, et al.
Cell Metabolism
|
January 9, 2021
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
Jingjing Cai, Haomiao Li, Changjiang Zhang, et al.
Cell Metabolism
|
May 6, 2020
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu, Zhi-Gang She, Xu Cheng, et al.
Cell Metabolism
|
June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Current Medical Research and Opinion
|
March 17, 2021
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients
Ze Chen, Jing Chen, Jianghua Zhou, et al.
Page
of 2